MedPath

CLAFORAN - PWS INJ 1.0G/VIAL

CLAFORAN - PWS INJ 1.0G/VIAL

Discontinued
DIN Number

02225093

Drug Class

Human

Market Date

Oct 10, 2003

Company
HC

sanofi-aventis canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02225093
AIG Number0152507001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01DD01 CEFOTAXIME
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous ,  Intramuscular
AHFS Classification08:12.06.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

CEFOTAXIME SODIUMActive
Strength: 1 G / VIAL
Monograph: CEFOTAXIME SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.